Increasing evidence suggests that ITGB1 is frequently upregulated in ovarian cancer, and promotes ovarian tumorigenesis and cancer progression.49 We found that HULC overexpression induces ITGB1 expression, while si-HULC overexpression had the opposite effect. Here, ITGB1 is linked to ovarian carcinoma.